You are here

Mayo Clinic Finds <i>C. Diff</i> Infection Risk Increases With Antihistamine Use to Treat Stomach Acid

Authors recommend judicious use of histamine 2 receptor antagonists (Mar. 27)

Patients receiving antihistamines to suppress stomach acid are at greater risk of infection from Clostridium difficile, a common cause of diarrhea, particularly in health care settings, according to Mayo Clinic researchers. The new study focused on histamine 2 receptor antagonists. The researchers found no significant risk for people taking over-the-counter antihistamine drugs, however. The findings were published online in PLoS One.

The researchers reviewed 35 observations based on 33 separate studies involving C. difficile and antihistamines used for stomach acid suppressive therapy. A clear association was found between the use of histamine 2 receptor antagonists and C. difficile infection. The investigators say this association was especially pronounced in and caused the greatest risk for hospitalized patients receiving antibiotics.

“It's not clear why these antihistamines increase the risk of C. diff infection, because gastric acid does not affect C. diff spores,” said senior author Larry Baddour, MD. “However, it may be that vegetative forms of C. diff, which are normally killed by stomach acid, survive due to the use of stomach acid suppressors and cause infection.”

According to the investigators, the study results highlight the need for judicious use of histamine 2 receptor antagonists in hospitalized patients, and suggest that reducing the use of these drugs could significantly reduce the risk of C. difficile infections.

Source: Mayo Clinic; March 27, 2013.

Recent Headlines

Findings from ISCHEMIA trial may mean fewer stents and bypass operations for those with stable disease
Donors hope to vaccinate 450 million children each year
New Novartis drug cuts rate of crises by 45% relative to placebo
FDA says new Pentax design is easier to clean
Myovant’s drug would offer a new oral, once-daily treatment option
More research is needed to confirm the finding
Study shows "complex genetic risk architecture"
Study says yes, interventions cuts need for meds
Review of 18 studies finds that medium doses have the strongest effects